141 related articles for article (PubMed ID: 3297374)
1. Prediction of normal tissue damage induced by cancer chemotherapy.
Vriesendorp HM; Vriesendorp R; Vriesendorp FJ
Cancer Chemother Pharmacol; 1987; 19(4):273-6. PubMed ID: 3297374
[TBL] [Abstract][Full Text] [Related]
2. Optimal prescription method for cancer chemotherapy.
Vriesendorp HM
Exp Hematol; 1985; 13 Suppl 16():57-63. PubMed ID: 3857184
[TBL] [Abstract][Full Text] [Related]
3. Body surface area estimation in children using weight alone: application in paediatric oncology.
Sharkey I; Boddy AV; Wallace H; Mycroft J; Hollis R; Picton S;
Br J Cancer; 2001 Jul; 85(1):23-8. PubMed ID: 11437397
[TBL] [Abstract][Full Text] [Related]
4. Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
Gurney H
J Clin Oncol; 1996 Sep; 14(9):2590-611. PubMed ID: 8823340
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic effects and mechanisms of Fufang e׳jiao jiang on radiotherapy and chemotherapy-induced myelosuppressed mice.
Liu M; Tan H; Zhang X; Liu Z; Cheng Y; Wang D; Wang F
J Ethnopharmacol; 2014 Mar; 152(3):575-84. PubMed ID: 24534527
[TBL] [Abstract][Full Text] [Related]
6. Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.
Song H; Vita M; Sallam H; Tehranchi R; Nilsson C; Sidén A; Hassan Z
Cancer Chemother Pharmacol; 2007 Nov; 60(6):841-9. PubMed ID: 17318617
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management.
Verstappen CC; Heimans JJ; Hoekman K; Postma TJ
Drugs; 2003; 63(15):1549-63. PubMed ID: 12887262
[TBL] [Abstract][Full Text] [Related]
8. Dose reduction of chemotherapeutic agents after weight loss.
O'Marcaigh AS; Gilchrist GS
Am J Clin Oncol; 1997 Apr; 20(2):193-5. PubMed ID: 9124199
[TBL] [Abstract][Full Text] [Related]
9. Practical treatment guide for dose individualisation in cancer chemotherapy.
Canal P; Chatelut E; Guichard S
Drugs; 1998 Dec; 56(6):1019-38. PubMed ID: 9878990
[TBL] [Abstract][Full Text] [Related]
10. Standardization of the body surface area (BSA) formula to calculate the dose of anticancer agents in Japan.
Kouno T; Katsumata N; Mukai H; Ando M; Watanabe T
Jpn J Clin Oncol; 2003 Jun; 33(6):309-13. PubMed ID: 12913086
[TBL] [Abstract][Full Text] [Related]
11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
12. High-dose chemotherapy: therapeutic potential in the age of growth factor support.
Ariad S; Bezwoda WR
Isr J Med Sci; 1992 Jun; 28(6):377-85. PubMed ID: 1607279
[TBL] [Abstract][Full Text] [Related]
13. Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
Costa LJ; Micallef IN; Inwards DJ; Johnston PB; Porrata LF; Litzow MR; Ansell SM
Br J Haematol; 2008 Oct; 143(2):268-73. PubMed ID: 18699848
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
[TBL] [Abstract][Full Text] [Related]
15. Use of body surface area (BSA)-based dosages to calculate chemotherapeutic drug dose in dogs: I. Potential problems with current BSA formulae.
Price GS; Frazier DL
J Vet Intern Med; 1998; 12(4):267-71. PubMed ID: 9686386
[TBL] [Abstract][Full Text] [Related]
16. Some effects of chemotherapeutic drugs on bone marrow stem cells. II. Effect on non-Hodgkin lymphoma chemotherapy on various hemopoietic compartments of the mouse.
Duménil D; Sainteny F; Frindel E
Cancer Chemother Pharmacol; 1979; 2(3):203-7. PubMed ID: 455576
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy.
Mauch P; Constine L; Greenberger J; Knospe W; Sullivan J; Liesveld JL; Deeg HJ
Int J Radiat Oncol Biol Phys; 1995 Mar; 31(5):1319-39. PubMed ID: 7713791
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2.
Schwartz J; Toste B; Dizon DS
Gynecol Oncol; 2009 Jul; 114(1):53-6. PubMed ID: 19359030
[TBL] [Abstract][Full Text] [Related]
19. Toxicity of dolastatin 10 in mice, rats and dogs and its clinical relevance.
Mirsalis JC; Schindler-Horvat J; Hill JR; Tomaszewski JE; Donohue SJ; Tyson CA
Cancer Chemother Pharmacol; 1999; 44(5):395-402. PubMed ID: 10501913
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
